I need a freelancer I am a freelancer Pitches

Alex Hewitt

Edinburgh, United Kingdom
Book Alex with Paydesk
See how it works

Book Alex with Paydesk

Make your booking securely through paydesk for these benefits:


Preferred Booking Channel

Alex is more likely to commit to assignments booked through paydesk, as it is a trusted platform that validates the seriousness and legitimacy of each engagement.

Insured Bookings for Peace of Mind

We provide basic insurance coverage with each booking on paydesk, giving both you and the media professional confidence and protection while they work for you.

Effortless Online Payment

Paydesk offers a payment protection system to ensure payments are only finalized when you are satisfied with the job completion. Freelancers trusts our process that guarantees their efforts are rewarded upon successful delivery of services

Still have questions?

Check FAQ
About Alex
Editorial and commerical photographer based in Edinburgh, United Kingdom. I tell stories for customers and help brands look their best.
Business Finance Politics

Seeing Neurodegeneration in a New Light Using Genetically Encoded Fluorescent Biosensors and iPSCs

16 Jan 2023
Neurodegenerative diseases are characterized by progressive neuronal loss, leading to brain atrophy. The mechanisms underlying neurodegeneration are not fully understood, which hampers the development of targeted therapies. Genetically encodable fluorescent biosensors (GEFBs) are engineered constructs that can sense changes in specific pathways, enzyme functions, or metabolite levels. When combined with induced pluripotent stem cells (iPSCs), GEFBs offer a powerful tool for exploring disease mechanisms and identifying novel therapeutics. This review discusses various GEFBs relevant to neurodegenerative diseases and their potential applications in iPSCs to illuminate unresolved questions about causes and risks for these conditions.

Cost-effectiveness of polygenic risk profiling for primary open-angle glaucoma in the United Kingdom and Australia

13 Dec 2022
A study evaluates the cost-effectiveness of polygenic risk score (PRS) profiling as a screening tool for primary open-angle glaucoma (POAG) in the UK and Australia. Using a Markov cohort model and published data, the study predicts the incremental cost-effectiveness ratio (ICER) for both countries, with results indicating that PRS screening is a promising cost-effectiveness strategy. The screening program is likely to be cost-effective in Australia at 79.2% and in the UK at 60.2%, based on respective willingness to pay thresholds.

Alex's confirmed information

Phone number
Verified Jul 2017
Jul 2017

Log in